Macular Degeneration Clinical Trials

Macular degeneration, also known as age-related macular degeneration (AMD), is a retinal condition that affects the macula, the part of the eye responsible for sharp central vision. As the condition progresses, activities such as reading, driving, recognizing faces, and seeing fine details may become more difficult.

AMD is one of the leading causes of vision loss among older adults and is generally classified as either dry AMD or wet AMD.

Dry AMD is the most common form of macular degeneration. It develops gradually as small deposits called drusen accumulate beneath the retina and portions of the macula become thinner over time. Vision changes often occur slowly and may become more noticeable as the condition progresses.

Wet AMD occurs when abnormal blood vessels grow beneath the retina and leak fluid or blood into the macula. Although less common than dry AMD, it is responsible for most cases of severe vision loss associated with macular degeneration. Symptoms may include blurred central vision, dark spots, or straight lines appearing distorted or wavy.

Submitting your information does not enroll you in a study. A member of our team will follow up to review your history and determine whether a current macular degeneration clinical trial may be a good fit.

For many individuals, macular degeneration raises concerns about how vision changes may affect everyday activities over time. Participating in clinical research can provide an opportunity to contribute to studies focused on better understanding conditions that impact central vision and retinal health.

At Equity Medical, participants are supported by experienced physicians, study coordinators, and research professionals who provide clear guidance throughout the study process. Our commitment to participant safety, ethical research practices, and data integrity helps ensure studies are conducted responsibly and with careful attention to quality.